DK1438040T4 - Farmaceutiske sammensætninger indeholdende mycophenolsyre eller et mycophenolsalt - Google Patents

Farmaceutiske sammensætninger indeholdende mycophenolsyre eller et mycophenolsalt Download PDF

Info

Publication number
DK1438040T4
DK1438040T4 DK02777314.2T DK02777314T DK1438040T4 DK 1438040 T4 DK1438040 T4 DK 1438040T4 DK 02777314 T DK02777314 T DK 02777314T DK 1438040 T4 DK1438040 T4 DK 1438040T4
Authority
DK
Denmark
Prior art keywords
mycophenolic
salt
pharmaceutical compositions
compositions containing
acid
Prior art date
Application number
DK02777314.2T
Other languages
English (en)
Other versions
DK1438040T3 (da
Inventor
Jürgen Dederichs
Thomas Rigassi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9924043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1438040(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of DK1438040T3 publication Critical patent/DK1438040T3/da
Application granted granted Critical
Publication of DK1438040T4 publication Critical patent/DK1438040T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK02777314.2T 2001-10-17 2002-10-16 Farmaceutiske sammensætninger indeholdende mycophenolsyre eller et mycophenolsalt DK1438040T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0124953.1A GB0124953D0 (en) 2001-10-17 2001-10-17 Organic Compounds
PCT/EP2002/011589 WO2003032978A1 (en) 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt

Publications (2)

Publication Number Publication Date
DK1438040T3 DK1438040T3 (da) 2008-02-04
DK1438040T4 true DK1438040T4 (da) 2020-01-27

Family

ID=9924043

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02777314.2T DK1438040T4 (da) 2001-10-17 2002-10-16 Farmaceutiske sammensætninger indeholdende mycophenolsyre eller et mycophenolsalt

Country Status (32)

Country Link
US (3) US20050013859A1 (da)
EP (1) EP1438040B2 (da)
JP (2) JP2005508959A (da)
KR (1) KR100671367B1 (da)
CN (1) CN1310640C (da)
AR (2) AR036813A1 (da)
AT (1) ATE374023T1 (da)
AU (1) AU2002338897B2 (da)
BR (1) BR0213355A (da)
CA (1) CA2460574A1 (da)
CO (1) CO5390076A1 (da)
CY (1) CY1107841T1 (da)
DE (1) DE60222687T3 (da)
DK (1) DK1438040T4 (da)
EC (2) ECSP024342A (da)
ES (1) ES2292819T5 (da)
GB (1) GB0124953D0 (da)
HK (1) HK1067861A1 (da)
HU (1) HU231114B1 (da)
IL (2) IL160968A0 (da)
MX (1) MXPA04003636A (da)
MY (1) MY139206A (da)
NO (1) NO341804B1 (da)
NZ (1) NZ532280A (da)
PE (1) PE20030476A1 (da)
PL (2) PL234541B1 (da)
PT (1) PT1438040E (da)
RU (2) RU2338528C2 (da)
SI (1) SI1438040T2 (da)
TW (1) TWI333861B (da)
WO (1) WO2003032978A1 (da)
ZA (1) ZA200401977B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
CN101014584A (zh) * 2004-07-20 2007-08-08 特瓦药厂私人有限公司 结晶霉酚酸钠的制备方法
GB0419355D0 (en) * 2004-08-31 2004-09-29 Novartis Ag Organic compounds
US20060235009A1 (en) * 2005-02-08 2006-10-19 Richard Glickman Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
EP1917010A2 (en) * 2005-02-08 2008-05-07 Aspreva Pharmaceuticals SA Compositions and methods for treating vascular, autoimmune and inflammatory diseases
BRPI0616640A2 (pt) * 2005-09-30 2011-06-28 Novartis Ag combinação de compostos orgánicos
US8597679B2 (en) 2005-12-21 2013-12-03 Basf Se Fine-particle crosslinked polyvinylpyrrolidone as tablet disintegrant
CN101378749A (zh) * 2006-02-13 2009-03-04 诺瓦提斯公司 高剂量的麦考酚酸(mpa)
WO2008148731A1 (de) 2007-06-06 2008-12-11 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
CN101707930B (zh) 2007-06-06 2013-10-30 巴斯夫欧洲公司 用于制备快速崩解的片剂的药物配制剂
KR20100063059A (ko) * 2007-08-13 2010-06-10 파나세아 바이오테크 리미티드 마이폴틱 장용정을 함유하는 서방출형 조성물 및 이의 조제방법
AU2009220779A1 (en) * 2008-03-05 2009-09-11 Panacea Biotec Limited Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
CN102099029A (zh) * 2008-07-09 2011-06-15 阿斯普瑞瓦国际公司 治疗眼部病症的霉酚酸钠的pH值特定溶液
WO2011046546A1 (en) * 2009-10-13 2011-04-21 Teva Pharmaceutical Industries Ltd. Delayed release compositions
US20110086102A1 (en) * 2009-10-13 2011-04-14 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011051967A2 (en) * 2009-10-23 2011-05-05 Alkem Laboratories Ltd Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
GB201100786D0 (en) 2011-01-18 2011-03-02 Ems Sa Pharmaceutical compositions of immunosuppressants
CN102793658A (zh) * 2012-08-23 2012-11-28 无锡福祈制药有限公司 一种含有麦考酚酸或麦考酚酸盐的骨架型制剂及其包衣片
CN103845323B (zh) * 2012-11-30 2018-02-02 重庆华邦制药有限公司 麦考酚酸及其盐肠溶制剂和制备方法
WO2014167442A1 (en) 2013-03-26 2014-10-16 Wockhardt Limited Pharmaceutical compositions comprising mycophenolic acid or salts thereof
CN106727403A (zh) * 2017-01-03 2017-05-31 无锡福祈制药有限公司 一种麦考酚钠肠溶片及其制备方法
KR20190131036A (ko) * 2017-03-13 2019-11-25 오카바 파마슈티컬즈 인코포레이티드 비-사람 포유동물에게 마이코페놀산 활성제를 전달하기 위한 방법 및 조성물
SG11202010322XA (en) * 2018-06-14 2020-11-27 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
RU2723255C2 (ru) * 2018-11-14 2020-06-09 Общество с ограниченной ответственностью "Изварино Фарма" Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы
JP2024506825A (ja) * 2021-01-28 2024-02-15 プリオセラ エスエーエス Ｓ１ｐ受容体調節剤による処置の方法
WO2022250977A1 (en) * 2021-05-26 2022-12-01 The Texas A&M University System Biodegradable mucoadhesive pharmaceutical formulations and methods thereof
CN117442580B (zh) * 2023-12-21 2024-04-05 泊诺(天津)创新医药研究有限公司 一种高生物利用度麦考酚钠肠溶片及其制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157099A (en) * 1966-09-27 1969-07-02 Ici Ltd Fermentation Process
GB1157100A (en) † 1966-09-27 1969-07-02 Ici Ltd Pharmaceutical Compositions
GB1203328A (en) * 1968-06-04 1970-08-26 Ici Ltd Pharmaceutical compositions
US3880995A (en) * 1973-05-14 1975-04-29 Lilly Co Eli Treatment of arthritis with mycophenolic acid and derivatives
JPS56127093A (en) * 1980-03-10 1981-10-05 Ajinomoto Co Inc Preparation of mycophenolic acid
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US5177072A (en) * 1987-01-30 1993-01-05 Syntex (U.S.A.) Inc. Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
WO1994012184A1 (en) * 1992-11-24 1994-06-09 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
EP0670724A1 (en) * 1992-11-24 1995-09-13 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
DK0686034T3 (da) * 1993-02-26 2001-08-27 Procter & Gamble Bisacodyl-doseringsform
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
EP0721335B1 (en) * 1993-10-01 2005-08-31 Roche Palo Alto LLC Mycophenolate mofetil high dose oral suspensions
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
AU7961094A (en) * 1993-10-19 1995-05-08 Procter & Gamble Company, The Picosulphate dosage form
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
DE60044717D1 (de) * 1999-05-10 2010-09-02 Paolo Brenner Kombination von immunsuppressiven substanzen zur behandlung oder vorbeugung von transplantat abstossungen
HUP9903226A2 (en) * 1999-09-23 2002-08-28 Gyogyszerki Process for producing mycophenolic acid and derivatives thereof
EP1259631B1 (en) * 2000-02-29 2005-10-12 Biocon Limited Manufacture and purification of mycophenolic acid
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
GB0124953D0 (en) 2001-12-05
NO341804B1 (no) 2018-01-22
CN1310640C (zh) 2007-04-18
KR20050037409A (ko) 2005-04-21
PE20030476A1 (es) 2003-07-30
JP2009137996A (ja) 2009-06-25
DK1438040T3 (da) 2008-02-04
ZA200401977B (en) 2006-05-31
DE60222687T2 (de) 2008-07-17
DE60222687D1 (de) 2007-11-08
BR0213355A (pt) 2006-05-23
RU2338528C2 (ru) 2008-11-20
SI1438040T1 (sl) 2008-04-30
PL234541B1 (pl) 2020-03-31
AR085778A2 (es) 2013-10-30
CO5390076A1 (es) 2004-04-30
ES2292819T5 (es) 2020-05-29
ES2292819T3 (es) 2008-03-16
US20120237601A1 (en) 2012-09-20
MXPA04003636A (es) 2004-07-27
RU2004115332A (ru) 2005-04-20
EP1438040B2 (en) 2019-10-16
SI1438040T2 (sl) 2020-02-28
EP1438040B1 (en) 2007-09-26
CN1564684A (zh) 2005-01-12
ECSP024341A (es) 2003-12-01
ATE374023T1 (de) 2007-10-15
CY1107841T1 (el) 2013-06-19
HK1067861A1 (en) 2005-04-22
CA2460574A1 (en) 2003-04-24
RU2381026C2 (ru) 2010-02-10
AU2002338897B2 (en) 2006-10-19
IL160968A0 (en) 2004-08-31
NZ532280A (en) 2007-05-31
AR036813A1 (es) 2004-10-06
NO20041785L (no) 2004-05-03
US20100210717A1 (en) 2010-08-19
US20050013859A1 (en) 2005-01-20
PL367738A1 (en) 2005-03-07
TWI333861B (en) 2010-12-01
EP1438040A1 (en) 2004-07-21
RU2007130786A (ru) 2009-02-20
WO2003032978A1 (en) 2003-04-24
MY139206A (en) 2009-08-28
HUP0600451A2 (en) 2006-09-28
HU231114B1 (hu) 2020-09-28
KR100671367B1 (ko) 2007-01-19
PL415001A1 (pl) 2016-02-29
IL160968A (en) 2016-04-21
JP2005508959A (ja) 2005-04-07
PT1438040E (pt) 2008-01-02
ECSP024342A (es) 2003-03-10
DE60222687T3 (de) 2020-03-05

Similar Documents

Publication Publication Date Title
DK1438040T4 (da) Farmaceutiske sammensætninger indeholdende mycophenolsyre eller et mycophenolsalt
DK1399153T3 (da) Farmaceutisk præparat indeholdende orlistat og en fedtsyre eller et salt deraf
NO2014011I1 (no) Vortioksetin eller et farmasøytisk akseptabelt syreaddisjonssalt dera
FI20011478A (fi) Farmaseuttinen koostumus
DE60206889D1 (de) Pharmazeutische formulierung enthaltend bicalutamid
DE60039598D1 (de) Pharmazeutische zusammensetzungen von erythropoietin
DK1395242T3 (da) Flydende farmaceutisk sammensætning
EE200200393A (et) Glüburiidi ravimkoostis
EE200300589A (et) Ravimkoostised
NO20035627D0 (no) Farmasöytisk formulering
NO20040860L (no) Farmasoytisk sammensetning som innbefatter lumiracoxib
FI20022128A (fi) Farmaseuttinen koostumus
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
ATE409032T1 (de) Orodispersible pharmazeutische zusammensetzung einer antithrombotischen verbindung
NO20033073D0 (no) Farmasöytisk sammensetning inneholdende citalopram
NO20042074L (no) Makrolider inneholdende farmasoytiske sammensetninger
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
NO20041236L (no) Farmasoytisk formulering
SE0100847D0 (sv) Novel pharmaceutical composition
SE0101325D0 (sv) Pharmaceutical formulation
SE0101326D0 (sv) Pharmaceutical formulation
SE0102069D0 (sv) Pharmaceutical formulation
SE0102572D0 (sv) Pharmaceutical formulation